Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dicks Sporting Goods Inc (DKS) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance

Dicks Sporting Goods IncTrade
Recursion Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Dicks Sporting Goods Inc vs Recursion Pharmaceuticals Inc — how do they compare? Dicks Sporting Goods Inc trades at $206.29 (market cap $18.35B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Dicks Sporting Goods Inc is far larger — about 10.1× Recursion Pharmaceuticals Inc's market cap, and Dicks Sporting Goods Inc pays a 2.44% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

DKSRXRX
Market Cap
$18.35B$1.81B
Sector
Consumer CyclicalHealth
52-Week High
$239.17$6.79
52-Week Low
$187.78$2.84
Enterprise Value
$25.14B$1.33B
Dividend Yield
2.44%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Dicks Sporting Goods Inc

Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.

Read more on DKS

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX